MedPath

KTP Green Light Prostatectomy Compared With Open Prostatectomy

Phase 4
Completed
Conditions
BPH (Benign Prostatic Hyperplasia)
Registration Number
NCT02072499
Lead Sponsor
University of Helsinki
Brief Summary

The purpose of this study is to compare safety and efficacy of Green Light PVP (Photoselective Vaporisation of the Prostate) compared to open prostatectomy when treating benign prostatic hyperplasia (BPH).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
40
Inclusion Criteria
  • Men undergoing surgery for BPH with prostate size more than 100cc
Exclusion Criteria
  • Previous prostate surgery
  • Carcinoma of the prostate
  • Neurogenic bladder
  • Bladder carcinoma

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
IPSS (International Prostate Symptom Score)12 months

symptom score

Secondary Outcome Measures
NameTimeMethod
IIEF (International Index of Erectile Function questionnaire)0,12 months
Perioperative bleedingTime of operation
IPSS (International Prostate Symptom Score)0, 3 and 6 months
Residual urine0, 3, 6 and 12 months
Prostate volume measured with TRUS (transrectal ultrasound)0, 12 moths
Rate of unscheduled hospital contacts12 months
DAN-PSS (Danish Prostate Symptom Score)0, 3, 6 and 12 months

symptom score

Maximum flow rate (Qmax)0, 3, 6 and 12 months
Length of catheterizationParticipants will be followed for the duration of hospital stay, an expected maximum of two weeks
Length of hospital stayParticipants will be followed for the duration of hospital stay, an expected maximum of two weeks

Trial Locations

Locations (1)

Helsinki University Hospital

🇫🇮

Helsinki, Finland

Helsinki University Hospital
🇫🇮Helsinki, Finland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.